Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
Rebecca Mellema: Journal Club Spotlight on Layilin and Platelet Hyperactivation in Inflammatory Bowel Disease
Rebecca Mellema/LinkedIn
Mar 26, 2026, 17:16

Rebecca Mellema: Journal Club Spotlight on Layilin and Platelet Hyperactivation in Inflammatory Bowel Disease

Rebecca Mellema, Freelance Science Communicator, shared a post on LinkedIn:

“New Journal Club video!

This time, we’ll be visiting my own paper: “Layilin inhibits integrin activation, and its loss results in platelet hyperactivation via Rac1 in inflammatory bowel disease.”

Authors: Mellema RA, Queisser KA, Ajanel A, Albtoush N, Smith-Sanchez L, Rondina MT, Will J, Valentine JF, Petrey AC.

Due to issues with Adobe Premier (and not wanting to waste all my footage), I had to split my video into 2 parts as well as delete some content, such as brief summaries of the experiments I like to have at the video intro. I apologize for that! It’s not my intention to cut out such a crucial part! (But I also had to stop my computer from crashing)”

Proceed to the videos (part one, part two) attached to the post.

Title: Layilin inhibits integrin activation, and its loss results in platelet hyperactivation via Rac1 in inflammatory bowel disease

Authors: Rebecca A. Mellema, Kimberly A. Queisser, Abigail Ajanel, Nansy Albtoush, Lydia Smith-Sanchez, Matthew T. Rondina, Julie Will, John F. Valentine, Aaron C. Petrey

Read the Full Article on Blood

Rebecca Mellema

Stay updated on all scientific advances with Hemostasis Today.

ASH Blood Health Hematology Hemophilia Hemostasis Hemostasis News Hemostasis Today Inflammatory Bowel Disease (IBD) Layilin Medicine Platelet Integrins Rac1 Rebecca Mellema
NewsFeed